[Which biological matrix for cannabis testing?].
Identifieur interne : 000B98 ( France/Analysis ); précédent : 000B97; suivant : 000B99[Which biological matrix for cannabis testing?].
Auteurs : J-P Goullé [France] ; C. LacroixSource :
- Annales pharmaceutiques francaises [ 0003-4509 ] ; 2006.
English descriptors
- KwdEn :
- MESH :
- chemical , analysis : Cannabinoids, Dronabinol.
- chemical , pharmacokinetics : Cannabinoids, Dronabinol.
- adverse effects : Cannabis.
- chemistry : Cannabis.
- Automobile Driving, Humans, Tissue Distribution.
Abstract
Decisive analytical progress for biological cannabis testing has been achieved over the past ten years. These major contributions allow to accurately identify and quantify in detail the substances present in the body following cannabinoid exposure. Fast and reliable onsite urine testing is used to implement the French law on narcotic drugs and its relationship to motorway safety. A positive test result will indicate a very recent exposure which is detectable up to five days following intake. Then a clinical examination and blood collection are performed by a physician, with a subsequent blood tetrahydrocannabinol (THC) analysis by authorized professionals registered at the judicial court of appeal. A result higher than the cut-off value is associated with a very recent cannabis exposure. Blood, urine, saliva and sweat cannabis determination are assessed according to the most recent pharmacokinetic and analytical data.
PubMed: 16710116
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000295
- to stream PubMed, to step Curation: 000295
- to stream PubMed, to step Checkpoint: 000295
- to stream Ncbi, to step Merge: 000154
- to stream Ncbi, to step Curation: 000154
- to stream Ncbi, to step Checkpoint: 000154
- to stream Main, to step Merge: 001065
- to stream Main, to step Curation: 001049
- to stream Main, to step Exploration: 001049
- to stream France, to step Extraction: 000B98
Links to Exploration step
pubmed:16710116Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Which biological matrix for cannabis testing?].</title><author><name sortKey="Goulle, J P" sort="Goulle, J P" uniqKey="Goulle J" first="J-P" last="Goullé">J-P Goullé</name><affiliation wicri:level="1"><nlm:affiliation>Laboratoire de pharmacocinétique et de toxicologie cliniques, Groupe hospitalier du Havre, BP 24, F 76083 Le Havre Cedex. jgoulle@ch-havre.fr</nlm:affiliation><country wicri:rule="url">France</country></affiliation></author><author><name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C" last="Lacroix">C. Lacroix</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16710116</idno><idno type="pmid">16710116</idno><idno type="wicri:Area/PubMed/Corpus">000295</idno><idno type="wicri:Area/PubMed/Curation">000295</idno><idno type="wicri:Area/PubMed/Checkpoint">000295</idno><idno type="wicri:Area/Ncbi/Merge">000154</idno><idno type="wicri:Area/Ncbi/Curation">000154</idno><idno type="wicri:Area/Ncbi/Checkpoint">000154</idno><idno type="wicri:doubleKey">0003-4509:2006:Goulle J:which:biological:matrix</idno><idno type="wicri:Area/Main/Merge">001065</idno><idno type="wicri:Area/Main/Curation">001049</idno><idno type="wicri:Area/Main/Exploration">001049</idno><idno type="wicri:Area/France/Extraction">000B98</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Which biological matrix for cannabis testing?].</title><author><name sortKey="Goulle, J P" sort="Goulle, J P" uniqKey="Goulle J" first="J-P" last="Goullé">J-P Goullé</name><affiliation wicri:level="1"><nlm:affiliation>Laboratoire de pharmacocinétique et de toxicologie cliniques, Groupe hospitalier du Havre, BP 24, F 76083 Le Havre Cedex. jgoulle@ch-havre.fr</nlm:affiliation><country wicri:rule="url">France</country></affiliation></author><author><name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C" last="Lacroix">C. Lacroix</name></author></analytic><series><title level="j">Annales pharmaceutiques francaises</title><idno type="ISSN">0003-4509</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Automobile Driving</term><term>Cannabinoids (analysis)</term><term>Cannabinoids (pharmacokinetics)</term><term>Cannabis (adverse effects)</term><term>Cannabis (chemistry)</term><term>Dronabinol (analysis)</term><term>Dronabinol (pharmacokinetics)</term><term>Humans</term><term>Tissue Distribution</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Cannabinoids</term><term>Dronabinol</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Cannabinoids</term><term>Dronabinol</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Cannabis</term></keywords><keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Cannabis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Automobile Driving</term><term>Humans</term><term>Tissue Distribution</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Decisive analytical progress for biological cannabis testing has been achieved over the past ten years. These major contributions allow to accurately identify and quantify in detail the substances present in the body following cannabinoid exposure. Fast and reliable onsite urine testing is used to implement the French law on narcotic drugs and its relationship to motorway safety. A positive test result will indicate a very recent exposure which is detectable up to five days following intake. Then a clinical examination and blood collection are performed by a physician, with a subsequent blood tetrahydrocannabinol (THC) analysis by authorized professionals registered at the judicial court of appeal. A result higher than the cut-off value is associated with a very recent cannabis exposure. Blood, urine, saliva and sweat cannabis determination are assessed according to the most recent pharmacokinetic and analytical data.</div></front></TEI><affiliations><list><country><li>France</li></country></list><tree><noCountry><name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C" last="Lacroix">C. Lacroix</name></noCountry><country name="France"><noRegion><name sortKey="Goulle, J P" sort="Goulle, J P" uniqKey="Goulle J" first="J-P" last="Goullé">J-P Goullé</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000B98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= France
|étape= Analysis
|type= RBID
|clé= pubmed:16710116
|texte= [Which biological matrix for cannabis testing?].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:16710116" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a LeHavreV1
| This area was generated with Dilib version V0.6.25. |  |